The kidney cancer drugs market comprises various therapeutic agents such as targeted therapies, cytokines, and chemotherapy drugs that are used for the treatment of renal cell cancer. Targeted therapies such as tyrosine kinase inhibitors and mTOR inhibitors have emerged as the most preferred treatment options owing to their higher efficacy and lesser side effects when compared with cy... https://articlescad.com/the-kidney-cancer-drugs-market-demand-is-driving-growth-through-immunotherapy-by-2031-295592.html